دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Advances in Image-Guided Adaptive Radiation Therapy
Jenny Bertholet,Yevgeniy Vinogradskiy,Yanle Hu,David J. Carlson
doi : 10.1016/j.ijrobp.2021.02.047
VOLUME 110, ISSUE 3, P625-628, JULY 01, 2021
The Red Journal's Top Reviewers from 2020
Anthony L. Zietman,Sue S. Yom
doi : 10.1016/j.ijrobp.2021.03.029
VOLUME 110, ISSUE 3, P629-630, JULY 01, 2021
Management Strategy of High-Risk Localized Prostate Cancer: Is there a Transatlantic Consensus?
Yazid Belkacemi,Gabriele Coraggio,Gokoulakrichenane Loganadaneon behalf of the Transatlantic Radiation Oncology Network (TRONE)
doi : 10.1016/j.ijrobp.2021.03.012
VOLUME 110, ISSUE 3, P631-632, JULY 01, 2021
A Trans-Atlantic Voyage of Extended ADT With Local Radiation
Ronald C. Chen
doi : 10.1016/j.ijrobp.2020.11.032
VOLUME 110, ISSUE 3, P633, JULY 01, 2021
Follow the Trials
Ashesh B. Jani
doi : 10.1016/j.ijrobp.2020.11.062
VOLUME 110, ISSUE 3, P634, JULY 01, 2021
Treating Localized High-Risk Prostate Cancer: Do All Roads Lead to Rome?
Osama Mohamad,Felix Feng
doi : 10.1016/j.ijrobp.2021.03.020
VOLUME 110, ISSUE 3, P634-635, JULY 01, 2021
Understanding Competing Risks
Ramsankar Basak,Hitesh Mistry,Ronald C. Chen
doi : 10.1016/j.ijrobp.2021.01.008
VOLUME 110, ISSUE 3, P636-640, JULY 01, 2021
Clinical Natural Language Processing for Radiation Oncology: A Review and Practical Primer
Danielle S. Bitterman,Timothy A. Miller,Raymond H. Mak,Guergana K. Savova
doi : 10.1016/j.ijrobp.2021.01.044
VOLUME 110, ISSUE 3, P641-655, JULY 01, 2021
Strategic Training in Transdisciplinary Radiation Science for the 21st Century (STARS21): 15-Year Evaluation of an Innovative Research Training Program
Parasvi S. Patel,Sobiga Vyravanathan,Emily Milne,Fei-Fei Liu,Marianne Koritzinsky,C. Anne Koch
doi : 10.1016/j.ijrobp.2021.01.010
VOLUME 110, ISSUE 3, P656-666, JULY 01, 2021
Assessment of Radiation Oncology Nurse Education in the United States
Marina Moskalenko,Jennifer Zaccone,Cheryl A. Fiscelli,Karyn A. Goodman,Daniel W. Golden,Sameer K. Nath
doi : 10.1016/j.ijrobp.2021.01.031
VOLUME 110, ISSUE 3, P667-671, JULY 01, 2021
Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer
Michael J. Zelefsky,Yoshiya Yamada,Carlo Greco,Simon N. Powell,Richard Kolesnick,Zvi Fuks
doi : 10.1016/j.ijrobp.2021.01.004
VOLUME 110, ISSUE 3, P672-679, JULY 01, 2021
Dose Escalation for Oligometastatic Disease: Is More Better?
Tithi Biswas,Daniel E. Spratt
doi : 10.1016/j.ijrobp.2021.02.031
VOLUME 110, ISSUE 3, P680-681, JULY 01, 2021
International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
Wai Tong Ng,Yoke Lim Soong,Yong Chan Ahn,Sue S. Yom,Melvin L.K. Chua,Anne W.M. Lee
doi : 10.1016/j.ijrobp.2021.01.041
VOLUME 110, ISSUE 3, P682-695, JULY 01, 2021
Flogging a Dead Salmon? Reduced Dose Posterior to Prostate Correlates With Increased PSA Progression in Voxel-Based Analysis of 3 Randomized Phase 3 Trials
Jane Shortall,Giuseppe Palma,Hitesh Mistry,Marianne Aznar,Marcel van Herk,Andrew Green
doi : 10.1016/j.ijrobp.2021.01.017
VOLUME 110, ISSUE 3, P696-699, JULY 01, 2021
Long-Term Results of NRG Oncology/RTOG 0321: A Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiation Therapy for Adenocarcinoma of the Prostate
I-Chow Hsu,Joseph P. Rodgers,Katsuto Shinohara,Gary S. Gustafson,Adam Raben,Howard M. Sandler
doi : 10.1016/j.ijrobp.2020.11.008
VOLUME 110, ISSUE 3, P700-707, JULY 01, 2021
Prostate Brachytherapy Boost: Where Are We and Where Are We Going
Robert T. Dess
doi : 10.1016/j.ijrobp.2021.02.051
VOLUME 110, ISSUE 3, P708-711, JULY 01, 2021
Receipt of Guideline-Recommended Surveillance in a Population-Based Cohort of Prostate Cancer Patients Undergoing Active Surveillance
Ronald C. Chen,Sabrina G. Prime,Ramsankar Basak,Claire Liang,Deborah S. Usinger,Aaron J. Katz
doi : 10.1016/j.ijrobp.2021.01.014
VOLUME 110, ISSUE 3, P712-715, JULY 01, 2021
Not So “Active” Surveillance
Christopher J.D. Wallis,Laurence Klotz,Raj Satkunasivam,Zachary Klaassen
doi : 10.1016/j.ijrobp.2021.01.030
VOLUME 110, ISSUE 3, P716-717, JULY 01, 2021
Comparative Effectiveness Research in Localized Prostate Cancer: A 10-Year Follow-up Cohort Study
Olatz Garin,José Francisco Su?rez,Ferran Guedea,Manel Castells,Montse FerrerMulticentric Spanish Group of Clinically Localized Prostate Cancer
doi : 10.1016/j.ijrobp.2020.12.032
VOLUME 110, ISSUE 3, P718-726, JULY 01, 2021
Quality of Life After Prostate Cancer Treatment
Amar U. Kishan,Sean P. Collins
doi : 10.1016/j.ijrobp.2021.03.017
VOLUME 110, ISSUE 3, P727-730, JULY 01, 2021
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients
Ritchell van Dams,Naomi Y. Jiang,Donald B. Fuller,Michael L. Steinberg,Tahmineh Romero,Amar U. Kishan
doi : 10.1016/j.ijrobp.2021.01.016
VOLUME 110, ISSUE 3, P731-737, JULY 01, 2021
Phase 1 Trial of Atezolizumab Plus Trimodal Therapy in Patients With Localized Muscle-Invasive Bladder Cancer
Gautier Marcq,Luis Souhami,Fabio L. Cury,Fadi Brimo,José Jo?o Mansure,Wassim Kassouf
doi : 10.1016/j.ijrobp.2020.12.033
VOLUME 110, ISSUE 3, P738-741, JULY 01, 2021
Can Hypofractionation and Immune Modulation Coexist?
Richard C. Walshaw,Peter J. Hoskin,Ananya Choudhury
doi : 10.1016/j.ijrobp.2021.02.052
VOLUME 110, ISSUE 3, P742-744, JULY 01, 2021
Interdisciplinary Clinical Target Volume Generation for Cardiac Radioablation: Multicenter Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial
Judit Boda-Heggemann,Oliver Blanck,Felix Mehrhof,Leif-Hendrik Boldt,Hendrik Bonnemeier,Boris Rudic
doi : 10.1016/j.ijrobp.2021.01.028
VOLUME 110, ISSUE 3, P745-756, JULY 01, 2021
The Plasma Levels and Polymorphisms of Vitronectin Predict Radiation Pneumonitis in Patients With Lung Cancer Receiving Thoracic Radiation Therapy
Jia-Hua Yu,Qing-Ya Zhao,Yuan Liu,Zhang-Ru Yang,Xiao-Long Fu,Xu-Wei Cai
doi : 10.1016/j.ijrobp.2021.01.018
VOLUME 110, ISSUE 3, P757-765, JULY 01, 2021
5-Year Outcomes of a Randomized Trial Comparing Prone and Supine Whole Breast Irradiation in Large-Breasted Women
Vincent Vakaet,Hans Van Hulle,Marie Vergotte,Chris Monten,Wilfried De Neve,Liv Veldeman
doi : 10.1016/j.ijrobp.2021.01.026
VOLUME 110, ISSUE 3, P766-771, JULY 01, 2021
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer
Asal Rahimi,Howard E. Morgan,Dong W. Kim,...Bo Zhao,Xuejun Gu,Robert Timmerman
doi : 10.1016/j.ijrobp.2021.01.015
VOLUME 110, ISSUE 3, P772-782, JULY 01, 2021
Breast Conservation in Women with Autoimmune Disease: The Role of Active Autoimmune Disease and Hypofractionation on Acute and Late Toxicity in a Case-Controlled Series
Juhi M. Purswani,Cheongeun Oh,Brian Jaros,Sabina Sandigursky,Julie Xiao,Naamit K. Gerber
doi : 10.1016/j.ijrobp.2021.01.047
VOLUME 110, ISSUE 3, P783-791, JULY 01, 2021
A Phase 2 Study of Dose-intensified Chemoradiation Using Biologically Based Target Volume Definition in Patients With Newly Diagnosed Glioblastoma
Michelle M. Kim,Yilun Sun,Madhava P. Aryal,Daniel R. Wahl,Theodore S. Lawrence,Yue Cao
doi : 10.1016/j.ijrobp.2021.01.033
VOLUME 110, ISSUE 3, P792-803, JULY 01, 2021
Treatment of WHO Grade 2 Meningiomas With Stereotactic Radiosurgery: Identification of an Optimal Group for SRS Using RPA
Roman O. Kowalchuk,Matthew J. Shepard,Kimball Sheehan,L. Dade Lunsford,Daniel M. Trifiletti,Jason P. Sheehan
doi : 10.1016/j.ijrobp.2021.01.048
VOLUME 110, ISSUE 3, P804-814, JULY 01, 2021
Proton Therapy for Pediatric Ependymoma: Mature Results From a Bicentric Study
Daniel J. Indelicato,Myrsini Ioakeim-Ioannidou,Julie A. Bradley,Nancy J. Tarbell,Torunn Yock,Shannon M. MacDonald
doi : 10.1016/j.ijrobp.2021.01.027
VOLUME 110, ISSUE 3, P815-820, JULY 01, 2021
Local Control For High-Grade Nonrhabdomyosarcoma Soft Tissue Sarcoma Assigned to Radiation Therapy on ARST0332: A Report From the Childrens Oncology Group
Lynn Million,Andrea Hayes-Jordan,Yueh-Yun Chi,Douglas S. Hawkins,Sheri L. Spunt,R. Lor Randall
doi : 10.1016/j.ijrobp.2021.01.051
VOLUME 110, ISSUE 3, P821-830, JULY 01, 2021
Risk-Adapted Radiation Deintensification in Children and Young Adults With Soft Tissue Sarcoma: New Questions Arise and Prior Questions Resurface
Daniel J. Indelicato,Meena Bedi
doi : 10.1016/j.ijrobp.2021.03.030
VOLUME 110, ISSUE 3, P831-832, JULY 01, 2021
Multicellular Spheroids as In Vitro Models of Oxygen Depletion During FLASH Irradiation
Syamantak Khan,Maxime Bassenne,Jinghui Wang,Lei Xing,Billy W. Loo Jr.,Guillem Pratx
doi : 10.1016/j.ijrobp.2021.01.050
VOLUME 110, ISSUE 3, P833-844, JULY 01, 2021
PI3K?? Inhibitor Combined With Radiation Enhances the Antitumor Immune Effect of Anti-PD1 in a Syngeneic Murine Triple-Negative Breast Cancer Model
Won Ick Chang,Min Guk Han,Mi Hyun Kang,Junhyung Bae,Soyeon Ahn,In Ah Kim
doi : 10.1016/j.ijrobp.2021.01.025
VOLUME 110, ISSUE 3, P845-858, JULY 01, 2021
CLTRN, Regulated by NRF1/RAN/DLD Protein Complex, Enhances Radiation Sensitivity of Hepatocellular Carcinoma Cells Through Ferroptosis Pathway
Yin Yuan,Wen Cao,Hongbing Zhou,Haixin Qian,Honggang Wang
doi : 10.1016/j.ijrobp.2020.12.062
VOLUME 110, ISSUE 3, P859-871, JULY 01, 2021
Electron FLASH Delivery at Treatment Room Isocenter for Efficient Reversible Conversion of a Clinical LINAC
Mahbubur Rahman,M. Ramish Ashraf,Rongxiao Zhang,P. Jack Hoopes,Brian W. Pogue,David J. Gladstone
doi : 10.1016/j.ijrobp.2021.01.011
VOLUME 110, ISSUE 3, P872-882, JULY 01, 2021
Early Prediction of Acute Esophagitis for Adaptive Radiation Therapy
Sadegh R. Alam,Pengpeng Zhang,Si-Yuan Zhang,Ellen D. Yorke,Joseph O. Deasy,Maria Thor
doi : 10.1016/j.ijrobp.2021.01.007
VOLUME 110, ISSUE 3, P883-892, JULY 01, 2021
Integrating Multiomics Information in Deep Learning Architectures for Joint Actuarial Outcome Prediction in Non-Small Cell Lung Cancer Patients After Radiation Therapy
Sunan Cui,Randall K. Ten Haken,Issam El Naqa
doi : 10.1016/j.ijrobp.2021.01.042
VOLUME 110, ISSUE 3, P893-904, JULY 01, 2021
In Regard to Polgar et al
Jayant S. Vaidya,Max Bulsara,Elena Sperk,Samuele Massarut,Michael Douek,Michael Alvarado,Steffi Pigorsch,Dennis Holmes,Marcelle Bernstein,Christobel Saunders,Henrik Flyger,David Joseph,Frederik Wenz,Jeffrey S. Tobias,on behalf of the TARGIT-A Investigators
doi : 10.1016/j.ijrobp.2021.01.059
VOLUME 110, ISSUE 3, P905-907, JULY 01, 2021
In Reply to Vaidya et al
Csaba Polg?r,Vratislav Strnad,Jean-Michel Hannoun-Levi,Tibor Major,Zolt?n Tak?csi-Nagy,J?nos Fodor
doi : 10.1016/j.ijrobp.2021.02.023
VOLUME 110, ISSUE 3, P907-908, JULY 01, 2021
In Regard to Rahman et al
Laurence J. Newell,Vikramaditya Bedi,James E. Clayton,Hsin L.u. Hsu,Daniel Pawlak,Lesitha Senadheera
doi : 10.1016/j.ijrobp.2021.03.046
VOLUME 110, ISSUE 3, P908-909, JULY 01, 2021
In Reply to Newell et al
Mahbubur Rahman,M. Ramish Ashraf,Rongxiao Zhang,Petr Bruza,Chad A. Dexter,Lawrence Thompson,Xu Cao,Benjamin B. Williams,P. Jack Hoopes,Brian W. Pogue,David J. Gladstone
doi : 10.1016/j.ijrobp.2021.03.045
VOLUME 110, ISSUE 3, P909-910, JULY 01, 2021
In Regard to Zelefsky et al
Kato Rans,Gert De Meerleer,Steven Joniau,Adinda Baten,Patrick Berkovic,Maarten Lambrecht,Charlien Berghen
doi : 10.1016/j.ijrobp.2021.02.038
VOLUME 110, ISSUE 3, P910-911, JULY 01, 2021
In Reply to Rans et al
Michael J. Zelefsky,Carlo Greco,Yoshiya Yamada,Simon N. Powell,Zvi Fuks
doi : 10.1016/j.ijrobp.2021.02.040
VOLUME 110, ISSUE 3, P911-912, JULY 01, 2021
In Regard to Parry et al
Stephen Langley,Robert Laing,Sara Khaksar,Sheel Mehta,Santiago Uribe-Lewis,Jennifer Uribe
doi : 10.1016/j.ijrobp.2021.02.036
VOLUME 110, ISSUE 3, P912-913, JULY 01, 2021
In Reply to Langley et al
Matthew G. Parry,Julie Nossiter,Arunan Sujenthiran,Thomas E. Cowling,Rajan N. Patel,Melanie Morris,Brendan Berry,Paul Cathcart,Noel W. Clarke,Jan van der Meulen,Ajay Aggarwal
doi : 10.1016/j.ijrobp.2021.02.037
VOLUME 110, ISSUE 3, P913-914, JULY 01, 2021
In Regard to Alam et al
Siamak Sabour
doi : 10.1016/j.ijrobp.2021.02.041
VOLUME 110, ISSUE 3, P914-915, JULY 01, 2021
In Reply to Sabour
Sadegh R. Alam,Pengpeng Zhang,Si-Yuan Zhang,Andreas Rimner,Neelam Tyagi,Yu-Chi Hu,Wei Lu,Ellen D. Yorke,Joseph O. Deasy,Maria Thor
doi : 10.1016/j.ijrobp.2021.02.039
VOLUME 110, ISSUE 3, P915-916, JULY 01, 2021
In Regard to Marcq et al
J. Khalifa,P. Sargos
doi : 10.1016/j.ijrobp.2021.01.058
VOLUME 110, ISSUE 3, P916-917, JULY 01, 2021
In Reply to Khalifa and Sargos
Gautier Marcq,Luis Souhami,Wassim Kassouf
doi : 10.1016/j.ijrobp.2021.01.057
VOLUME 110, ISSUE 3, P917-918, JULY 01, 2021
In Regard to Parry et al
Vedang Murthy,Shashank Srinivasan
doi : 10.1016/j.ijrobp.2021.01.036
VOLUME 110, ISSUE 3, P918, JULY 01, 2021
In Regard to Salama et al
Stephanie Perkins,Dennis E. Hallahan,Julie K. Schwarz
doi : 10.1016/j.ijrobp.2021.02.002
VOLUME 110, ISSUE 3, P918-919, JULY 01, 2021
Challenges and Opportunities for Radiation Oncology Residency Programs During the 2020-2021 Virtual Residency Match
Bismarck C. Odei,Junu Bae,Dalia Littman,Alejandra Zaleta Lastra,Austin Morgan,Temitope Agabalogun,Sofia Herrera,James Odei,Denise Fabian,Fumiko Chino
doi : 10.1016/j.ijrobp.2021.02.010
VOLUME 110, ISSUE 3, P919-921, JULY 01, 2021
Erratum to: Abdel-Wahab M, Rosenblatt E, Prajogi B, Zubizarretta E, Mikhail M. Opportunities in Telemedicine, Lessons Learned After COVID-19 and the Way Into the Future. Int J Radiat Oncol Biol Phys 2020:108(2);438-443.
doi : 10.1016/j.ijrobp.2021.02.026
VOLUME 110, ISSUE 3, P922, JULY 01, 2021
